Advanced Enzyme Technologies Limited

NSEI:ADVENZYMES Stok Raporu

Piyasa değeri: ₹53.5b

Advanced Enzyme Technologies Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 4/6

Advanced Enzyme Technologies's earnings have been declining at an average annual rate of -1.3%, while the Chemicals industry saw earnings growing at 15.6% annually. Revenues have been growing at an average rate of 7.3% per year. Advanced Enzyme Technologies's return on equity is 10.4%, and it has net margins of 22%.

Anahtar bilgiler

-1.3%

Kazanç büyüme oranı

-1.4%

EPS büyüme oranı

Chemicals Sektör Büyümesi17.7%
Gelir büyüme oranı7.3%
Özkaynak getirisi10.4%
Net Marj22.0%
Sonraki Kazanç Güncellemesi09 Nov 2024

Yakın geçmiş performans güncellemeleri

Recent updates

After Leaping 26% Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Shares Are Not Flying Under The Radar

Aug 20
After Leaping 26% Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Shares Are Not Flying Under The Radar

We Think Shareholders Are Less Likely To Approve A Pay Rise For Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) CEO For Now

Jul 19
We Think Shareholders Are Less Likely To Approve A Pay Rise For Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) CEO For Now

Advanced Enzyme Technologies (NSE:ADVENZYMES) Has Affirmed Its Dividend Of ₹1.00

Jul 13
Advanced Enzyme Technologies (NSE:ADVENZYMES) Has Affirmed Its Dividend Of ₹1.00

Advanced Enzyme Technologies' (NSE:ADVENZYMES) Returns On Capital Not Reflecting Well On The Business

Apr 08
Advanced Enzyme Technologies' (NSE:ADVENZYMES) Returns On Capital Not Reflecting Well On The Business

Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends

Sep 23
Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends

Advanced Enzyme Technologies (NSE:ADVENZYMES) Could Be Struggling To Allocate Capital

Feb 03
Advanced Enzyme Technologies (NSE:ADVENZYMES) Could Be Struggling To Allocate Capital

Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends

Aug 11
Advanced Enzyme Technologies (NSE:ADVENZYMES) Will Want To Turn Around Its Return Trends

With EPS Growth And More, Advanced Enzyme Technologies (NSE:ADVENZYMES) Is Interesting

May 13
With EPS Growth And More, Advanced Enzyme Technologies (NSE:ADVENZYMES) Is Interesting

Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Paint A Concerning Picture

Mar 28
Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Paint A Concerning Picture

The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 185%, So Why Not Pay It Some Attention?

Mar 13
The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 185%, So Why Not Pay It Some Attention?

Don't Ignore The Fact That This Insider Just Sold Some Shares In Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)

Feb 21
Don't Ignore The Fact That This Insider Just Sold Some Shares In Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)

Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Feb 18
Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

I Built A List Of Growing Companies And Advanced Enzyme Technologies (NSE:ADVENZYMES) Made The Cut

Feb 03
I Built A List Of Growing Companies And Advanced Enzyme Technologies (NSE:ADVENZYMES) Made The Cut

What Kind Of Investors Own Most Of Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)?

Jan 19
What Kind Of Investors Own Most Of Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)?

What Do The Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Tell Us?

Dec 28
What Do The Returns On Capital At Advanced Enzyme Technologies (NSE:ADVENZYMES) Tell Us?

The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 114%, So Why Not Pay It Some Attention?

Dec 13
The Advanced Enzyme Technologies (NSE:ADVENZYMES) Share Price Has Gained 114%, So Why Not Pay It Some Attention?

Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?

Nov 28
Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?

Are Strong Financial Prospects The Force That Is Driving The Momentum In Advanced Enzyme Technologies Limited's NSE:ADVENZYMES) Stock?

Nov 20
Are Strong Financial Prospects The Force That Is Driving The Momentum In Advanced Enzyme Technologies Limited's NSE:ADVENZYMES) Stock?

Here's Why I Think Advanced Enzyme Technologies (NSE:ADVENZYMES) Might Deserve Your Attention Today

Nov 05
Here's Why I Think Advanced Enzyme Technologies (NSE:ADVENZYMES) Might Deserve Your Attention Today

What You Need To Know About Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Investor Composition

Oct 21
What You Need To Know About Advanced Enzyme Technologies Limited's (NSE:ADVENZYMES) Investor Composition

Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?

Oct 06
Have Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Insiders Been Selling Their Stock?

Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Stocks Shoot Up 31% But Its P/E Still Looks Reasonable

Sep 26
Advanced Enzyme Technologies Limited (NSE:ADVENZYMES) Stocks Shoot Up 31% But Its P/E Still Looks Reasonable

Gelir ve Gider Dağılımı

Advanced Enzyme Technologies nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

NSEI:ADVENZYMES Gelir, gider ve kazançlar (INR Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 246,3111,3861,3940
31 Mar 246,2391,3331,3610
31 Dec 236,0481,3711,3270
30 Sep 235,8591,2481,2960
30 Jun 235,6681,1661,2570
31 Mar 235,4061,0561,2170
31 Dec 225,3379791,1670
30 Sep 225,2519601,1310
30 Jun 225,1359951,1110
31 Mar 225,2941,1961,0990
31 Dec 215,3091,2681,0400
30 Sep 215,3501,4241,0000
30 Jun 215,3251,5009300
31 Mar 215,0181,4598980
31 Dec 204,8201,4598910
30 Sep 204,5691,3648680
30 Jun 204,4811,3018590
31 Mar 204,4401,2938520
31 Dec 194,4801,3028710
30 Sep 194,3661,2109000
30 Jun 194,2881,1488910
31 Mar 194,2201,1118880
31 Dec 184,1941,0618730
30 Sep 184,2611,0688380
30 Jun 184,1991,0397370
31 Mar 183,9189017520
31 Dec 173,6608376870
30 Sep 173,2137256240
30 Jun 173,1277935920
31 Mar 173,2909155460
31 Dec 163,2609425360
30 Sep 163,4049985210
30 Jun 163,1848544890
31 Mar 162,9387594860
31 Mar 152,2335104010
31 Mar 142,3972013650

Kaliteli Kazançlar: ADVENZYMES has high quality earnings.

Büyüyen Kar Marjı: ADVENZYMES's current net profit margins (22%) are higher than last year (20.6%).


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: ADVENZYMES's earnings have declined by 1.3% per year over the past 5 years.

Büyüme Hızlandırma: ADVENZYMES's earnings growth over the past year (18.9%) exceeds its 5-year average (-1.3% per year).

Kazançlar vs. Sektör: ADVENZYMES earnings growth over the past year (18.9%) exceeded the Chemicals industry 10.4%.


Özkaynak Getirisi

Yüksek ROE: ADVENZYMES's Return on Equity (10.4%) is considered low.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin